LS mean change from baseline (SE) | Day 1 | Day 28 | ||||
Placebo | FF/VI | Tx Diff (95% CI) | Placebo | FF/VI | Tx Diff (95% CI) | |
Predose | – | – | – | 0.022 (0.0365) | 0.223 (0.0234) | 0.201 (0.113 to 0.288) |
5 min | 0.009 (0.0219) | 0.140 (0.0151) | 0.131 (0.077 to 0.184) | 0.038 (0.0370) | 0.254 (0.0237) | 0.216 (0.127 to 0.305) |
15 min | 0.038 (0.0282) | 0.187 (0.0199) | 0.149 (0.080 to 0.219) | 0.055 (0.0390) | 0.279 (0.0249) | 0.224 (0.130 to 0.317) |
30 min | 0.026 (0.0273) | 0.205 (0.0193) | 0.179 (0.112 to 0.246) | 0.054 (0.0402) | 0.278 (0.0256) | 0.225 (0.129 to 0.321) |
60 min | 0.025 (0.0265) | 0.213 (0.0186) | 0.188 (0.123 to 0.253) | 0.071 (0.0382) | 0.297 (0.0243) | 0.226 (0.135 to 0.317) |
120 min | 0.028 (0.0285) | 0.235 (0.0202) | 0.207 (0.137 to 0.277) | 0.063 (0.0361) | 0.285 (0.0231) | 0.222 (0.135 to 0.308) |
240 min | −0.003 (0.0358) | 0.261 (0.0253) | 0.265 (0.176 to 0.353) | 0.052 (0.0394) | 0.278 (0.0252) | 0.226 (0.132 to 0.321) |
FF, fluticasone furoate; LS, least squares; Tx, treatment; VI, vilanterol.